Tonghe Pharmaceutical announced that Pang Zhengwei, the controlling shareholder and one of the actual controllers of the company, plans to increase his holdings of the company's shares through centralized bidding, bulk transactions, or other methods permitted by laws and regulations. The increase in holdings is not less than 10 million yuan and not more than 15 million yuan. The implementation period of the increase plan is within 6 months from the date of disclosure of this announcement.

Tonghe Pharmaceutical announced that Pang Zhengwei, the controlling shareholder and one of the actual controllers of the company, plans to increase his holdings of the company's shares through centralized bidding, bulk transactions, or other methods permitted by laws and regulations. The increase in holdings is not less than 10 million yuan and not more than 15 million yuan. The implementation period of the increase plan is within 6 months from the date of disclosure of this announcement.